-
Treatment Patterns and Triple Therapy Utilization in Chinese Patients with Chronic Obstructive Pulmonary Disease: An Analysis of Real-World Data from the Yinzhou Database
29 Jul 2025 15:26 GMT
… , KRONOS, and ETHOS trials, triple therapies for COPD … prescriptions of the same drug class was ≤ 60 … medications, especially triple therapy, in China. Future research may explore the treatment … mortality in the ETHOS trial of budesonide/glycopyrrolate…
-
EMA Approves Lower GWP Alternative for Inhalation Medicine
25 Jul 2025 19:35 GMT
… gas propellant used in budesonide/glycopyrronium…
AstraZeneca AB, the drug’s marketing authorization holder … Potential ensures clinicians’ treatment decisions can focus on … ;first-reformulation-inhaled-medicine-environmentally-friendly-gas-propellant …
-
First reformulation of an inhaled medicine with environmentally friendly gas propellant
25 Jul 2025 10:01 GMT
… small particles of active pharmaceutical ingredients that are then … same performance properties for the medicinal product.
The reformulated Trixeo… (budesonide, glycopyrronium, formoterol fumarate dihydrate) are currently approved for maintenance treatment …
-
Integrative Network Pharmacology and Transcriptomics Reveal the Mechanism of Gui-Qi-Yi-Shen Granules in the Treatment of IgA Nephropathy
22 Jul 2025 17:07 GMT
… IgAN treatment, including SGLT-2 inhibitors, gut-targeted budesonide (Nefecon … sequencing is performed by OE Biotech, Inc. (Shanghai, China … . Third, randomized clinical trial data on GQYS is … of new traditional Chinese medicine drugs and suggest promising …
-
Safety Profile of Budesonide Oral Suspension
21 Jul 2025 12:58 GMT
Panelists discuss how budesonide oral suspension demonstrates a … FDA-approved specifically for esophageal delivery rather than repurposing lung medications … , which eliminates variability in homemade formulations and ensures consistent drug …
-
Budesonide Oral Suspension for EoE: Advantages and Clinical Efficacy
21 Jul 2025 12:59 GMT
Panelists discuss how budesonide oral suspension was developed as … largest US eosinophilic esophagitis (EoE) trial, with 62% of patients achieving …
-
Albuterol-Budesonide Lowers Severe Exacerbations in Mild Asthma
15 Jul 2025 19:26 GMT
… New England Journal of Medicine reported the results of a … , double-blind, event-driven trial. Included were patients aged 12 … alone at baseline. The trial was halted for efficacy at … two treatment groups, they advised.
“As-needed use of albuterol–budesonide …
-
Uncovering Link Between Microscopic Colitis, Certain Medications
09 Jul 2025 05:54 GMT
… as certain medications, such as budesonide, bile acid … medications on risk for MC.
The emulation of six target trials … 5% under all treatment strategies. The … drug initiation versus noninitiation
• Proton-pump inhibitor initiation versus noninitiation
• Statin …
-
Cutting Red Tape To Improve Medicines Access
09 Jul 2025 01:33 GMT
… decision-making
processes around medicines – this is … approach to funding medicines. My
expectation is … budesonide
with eformoterol inhalers on a Practitioners Supply Order
(PSO), meaning doctors … - negotiating the best medical deals for New
Zealanders.” …
-
Q&A: Albuterol-budesonide reduces severe exacerbation risks in mild asthma
02 Jul 2025 13:01 GMT
… — A fixed-dose of albuterol-budesonide used as needed reduced risks … are the key takeaways for doctors and who might be … anti-inflammatory component to its treatment, and it can be just … Sanofi U.S. Services, and Medicolegal Consulting; a speaker role with …